Emerald Health Sciences Inc., 10% Owner at Skye Bioscience, Inc. (SKYE), sold 2,566,666 shares at $0.10 ($257K) on 2020-08-07, disclosed to the SEC on 2022-01-31.
Open-market sale of $257k SKYE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.